The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Open accessAbstract
BACKGROUND: Antibiotics alter the microbial balance commonly resulting in antibiotic-associated diarrhea (AAD). Probiotics may prevent AAD via providing gut barrier, restoration of the gut microflora, and other potential mechanisms of action. OBJECTIVES: The primary objectives were to assess the efficacy and safety of probiotics (any specified strain or dose) used for the prevention of AAD in children. SEARCH METHODS: MEDLINE, Embase, CENTRAL, CINAHL, and the Web of Science (inception to 28 May 2018) were searched along with registers including the ISRCTN and Clinicaltrials.gov. We also searched the NICE Evidence Services database as well as reference lists from relevant articles. SELECTION CRITERIA: Randomized, parallel, controlled trials in children (0 to 18 years) receiving antibiotics, that compare probiotics to placebo, active alternative prophylaxis, or no treatment and measure the incidence of diarrhea secondary to antibiotic use were considered for inclusion. DATA COLLECTION AND ANALYSIS: Study selection, data extraction, and risk of bias assessment were conducted independently by two authors. Dichotomous data (incidence of AAD, adverse events) were combined using a pooled risk ratio (RR) or risk difference (RD), and continuous data (mean duration of diarrhea) as mean difference (MD), along with corresponding 95% confidence interval (95% CI). We calculated the number needed to treat for an additional beneficial outcome (NNTB) where appropriate. For studies reporting on microbiome characteristics using heterogeneous outcomes, we describe the results narratively. The certainty of the evidence was evaluated using GRADE. MAIN RESULTS: Thirty-three studies (6352 participants) were included. Probiotics assessed included Bacillus spp., Bifidobacterium spp., Clostridium butyricum, Lactobacilli spp., Lactococcus spp., Leuconostoc cremoris, Saccharomyces spp., orStreptococcus spp., alone or in combination. The risk of bias was determined to be high in 20 studies and low in 13 studies. Complete case (patients who did not complete the studies were not included in the analysis) results from 33 trials reporting on the incidence of diarrhea show a precise benefit from probiotics compared to active, placebo or no treatment control.After 5 days to 12 weeks of follow-up, the incidence of AAD in the probiotic group was 8% (259/3232) compared to 19% (598/3120) in the control group (RR 0.45, 95% CI 0.36 to 0.56; I² = 57%, 6352 participants; NNTB 9, 95% CI 7 to 13; moderate certainty evidence). Nineteen studies had loss to follow-up ranging from 1% to 46%. After making assumptions for those lost, the observed benefit was still statistically significant using an extreme plausible intention-to-treat (ITT) analysis, wherein the incidence of AAD in the probiotic group was 12% (436/3551) compared to 19% (664/3468) in the control group (7019 participants; RR 0.61; 95% CI 0.49 to 0.77; P <0.00001; I² = 70%). An a priori available case subgroup analysis exploring heterogeneity indicated that high dose (≥ 5 billion CFUs per day) is more effective than low probiotic dose (< 5 billion CFUs per day), interaction P value = 0.01. For the high dose studies the incidence of AAD in the probiotic group was 8% (162/2029) compared to 23% (462/2009) in the control group (4038 participants; RR 0.37; 95% CI 0.30 to 0.46; P = 0.06; moderate certainty evidence). For the low dose studies the incidence of AAD in the probiotic group was 8% (97/1155) compared to 13% (133/1059) in the control group (2214 participants; RR 0.68; 95% CI 0.46 to 1.01; P = 0.02). Again, assumptions for loss to follow-up using an extreme plausible ITT analysis was statistically significant. For high dose studies the incidence of AAD in the probiotic group was 13% (278/2218) compared to 23% (503/2207) in control group (4425 participants; RR 0.54; 95% CI 0.42 to 0.70; P <0.00001; I² = 68%; moderate certainty evidence).None of the 24 trials (4415 participants) that reported on adverse events reported any serious adverse events attributable to probiotics. Adverse event rates were low. After 5 days to 4 weeks follow-up, 4% (86/2229) of probiotics participants had an adverse event compared to 6% (121/2186) of control participants (RD 0.00; 95% CI -0.01 to 0.01; P < 0.00001; I² = 75%; low certainty evidence). Common adverse events included rash, nausea, gas, flatulence, abdominal bloating, and constipation.After 10 days to 12 weeks of follow-up, eight studies recorded data on our secondary outcome, the mean duration of diarrhea; with probiotics reducing diarrhea duration by almost one day (MD -0.91; 95% CI -1.38 to -0.44; P <0.00001; low certainty evidence). One study reported on microbiome characteristics, reporting no difference in changes with concurrent antibiotic and probiotic use. AUTHORS' CONCLUSIONS: The overall evidence suggests a moderate protective effect of probiotics for preventing AAD (NNTB 9, 95% CI 7 to 13). Using five criteria to evaluate the credibility of the s
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Dietary modulation of the human colonic microbiota: updating the concept of prebiotics
Gibson, G. R., Probert, H. M., Loo, J. V., Rastall, R. A., & Roberfroid, M. B. (2004) · Nutrition Research Reviews · doi:10.1079/nrr200479 · Cited by 2,536
Janda, J. M., & Abbott, S. L. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01228-07 · Cited by 2,216
What is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160
The case of the misleading funnel plot
Lau, J., Ioannidis, J. P. A., Terrin, N., Schmid, C. H., & Olkin, I. (2006) · BMJ · doi:10.1136/bmj.333.7568.597 · Cited by 1,766
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593
Probiotics, prebiotics, and synbiotics—approaching a definition
Schrezenmeir, J., & de Vrese, M. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.361s · Cited by 1,516
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia
Bartlett, J. G., Chang, T. W., Gurwith, M., Gorbach, S. L., & Onderdonk, A. B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197803092981003 · Cited by 1,374
The appropriateness of asymmetry tests for publication bias in meta-analyses: A large survey
Ioannidis, J. P. A., & Trikalinos, T. A. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060410 · Cited by 1,052
Saavedra, J. M., Bauman, N. A., Perman, J. A., Yolken, R. H., Saavedra, J. M., Bauman, N. A., & Oung, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91708-6 · Cited by 970
Demonstration of safety of probiotics—A review
Salminen, S. (1998) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(98)00128-7 · Cited by 884
McFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872 · cited 1×
“The results of diverse probiotic agents co-administered with antibiotics favoured probiotics (RR 0.43; 95% CI 0.31 to 0.58; McFarland 2006; RR 0.48; 95% CI 0.35 to 0.65; Sazawal 2006; RR 0.40; 95% CI 0.28 to 0.57; Cremonini 2002 and OR 0.37; 95% CI 0.26 to 0.53; D’Souza 2002).”
InfluentialIs a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
Sun, X., Briel, M., Walter, S. D., & Guyatt, G. H. (2010) · BMJ · doi:10.1136/bmj.c117 · Cited by 808
Interpretation of tests of heterogeneity and bias in meta-analysis
Ioannidis, J. P. A. (2008) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.00986.x · Cited by 696
Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis
D'Souza, A. L., Rajkumar, C., Cooke, J., & Bulpitt, C. J. (2002) · BMJ · doi:10.1136/bmj.324.7350.1361 · Cited by 664
Lin, H.-C., Su, B.-H., Chen, A.-C., Lin, T.-W., Tsai, C.-H., Yeh, T.-F., & Oh, W. (2005) · Pediatrics · doi:10.1542/peds.2004-1463 · Cited by 660
Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection
Owens, Jr., Donskey, C. J., Gaynes, R. P., Loo, V. G., & Muto, C. A. (2008) · Clinical Infectious Diseases · doi:10.1086/521859 · Cited by 603
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599
Oral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight Neonates
Bin-Nun, A., Bromiker, R., Wilschanski, M., Kaplan, M., Rudensky, B., Caplan, M., & Hammerman, C. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.03.054 · Cited by 590
Sazawal, S., Hiremath, G., Dhingra, U., Malik, P., Deb, S., & Black, R. E. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70495-9 · Cited by 561
Safety of Probiotics That Contain Lactobacilli or Bifidobacteria
Borriello, S. P., Hammes, W. P., Holzapfel, W., Marteau, P., Schrezenmeir, J., Vaara, M., & Valtonen, V. (2003) · Clinical Infectious Diseases · doi:10.1086/368080 · Cited by 551
How to Use a Subgroup Analysis: Users’ Guide to the Medical Literature
Sun, X., Ioannidis, J. P. A., Agoritsas, T., Alba, A. C., & Guyatt, G. (2014) · JAMA · doi:10.1001/jama.2013.285063 · Cited by 550
Weizman, Z., Asli, G., & Alsheikh, A. (2005) · Pediatrics · doi:10.1542/peds.2004-1815 · Cited by 548
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients
McFarland, L. V. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i18.2202 · Cited by 545
Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children
Vanderhoof, J. A., Whitney, D. B., Antonson, D. L., Hanner, T. L., Lupo, J. V., & Young, R. J. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70053-3 · Cited by 536
Standardising outcomes for clinical trials and systematic reviews
Clarke, M. (2007) · Trials · doi:10.1186/1745-6215-8-39 · Cited by 483
Ferreira-González, I., Permanyer-Miralda, G., Domingo-Salvany, A., Busse, J. W., Heels-Ansdell, D., Montori, V. M., Akl, E. A., Bryant, D. M., Alonso-Coello, P., Alonso, J., et al. (2007) · BMJ · doi:10.1136/bmj.39136.682083.ae · Cited by 473
Wistrom, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.1.43 · Cited by 448
Arvola, T., Laiho, K., Torkkeli, S., Mykkänen, H., Salminen, S., Maunula, L., & Isolauri, E. (1999) · Pediatrics · doi:10.1542/peds.104.5.e64 · Cited by 427
Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380455 · Cited by 426
Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants
Szajewska, H., Kotowska, M., Mrukowicz, J. Z., Arma′nska, M., & Mikolajczyk, W. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.111321 · Cited by 409
Meta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoea
Cremonini, F., Di Caro, S., Nista, E. C., Bartolozzi, F., Capelli, G., Gasbarrini, G., & Gasbarrini, A. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01318.x · Cited by 384
A systematic review of the safety of probiotics
Didari, T., Solki, S., Mozaffari, S., Nikfar, S., & Abdollahi, M. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.872627 · Cited by 367
Risk of bias versus quality assessment of randomised controlled trials: cross sectional study
Hartling, L., Ospina, M., Liang, Y., Dryden, D. M., Hooton, N., Krebs Seida, J., & Klassen, T. P. (2009) · BMJ · doi:10.1136/bmj.b4012 · Cited by 348
Prebiotics and synbiotics: concepts and nutritional properties
Roberfroid, M. B. (1998) · British Journal of Nutrition · doi:10.1017/s0007114500006024 · Cited by 346
Probiotic Prophylaxis of Ventilator-associated Pneumonia: A Blinded, Randomized, Controlled Trial
Morrow, L. E., Kollef, M. H., & Casale, T. B. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1853oc · Cited by 346
Antibiotic-Associated Diarrhea: Epidemiology, Trends and Treatment
McFarland, L. V. (2008) · Future Microbiology · doi:10.2217/17460913.3.5.563 · Cited by 333
Liver Abscess Due to a Lactobacillus rhamnosus Strain Indistinguishable from L. rhamnosus Strain GG
Rautio, M., Jousimies‐Somer, H., Kauma, H., Pietarinen, I., Saxelin, M., Tynkkynen, S., & Koskela, M. (1999) · Clinical Infectious Diseases · doi:10.1086/514766 · Cited by 327
Effect of Lactobacillus GG Yoghurt in Prevention of Antibiotic Associated Diarrhoea
Siitonen, S., Vapaatalo, H., Salminen, S., Gordin, A., Saxelin, M., Wikberg, R., & Kirkkola, A.-L. (1990) · Annals of Medicine · doi:10.3109/07853899009147243 · Cited by 326
Dietary modulation of the human gut microflora using prebiotics
Gibson, G. R. (1998) · British Journal of Nutrition · doi:10.1017/s0007114500006048 · Cited by 322
Goldin, B. R. (1998) · British Journal of Nutrition · doi:10.1017/s0007114500006036 · Cited by 320
Epidemiology, Risk Factors and Treatments for Antibiotic-Associated Diarrhea
McFarland, L. V. (1998) · Digestive Diseases · doi:10.1159/000016879 · Cited by 310
Szajewska, H., Ruszczyński, M., & Radzikowski, A. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.04.053 · Cited by 303
Kotowska, M., Albrecht, P., & Szajewska, H. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02356.x · Cited by 286
Lactobacillus endocarditis caused by a probiotic organism
Mackay, A. D., Taylor, M. B., Kibbler, C. C., & Hamilton-Miller, J. M. T. (1999) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1999.tb00144.x · Cited by 264
Prevention of antibiotic‐associated diarrhea in children by Clostridium butyricum MIYAIRI
SEKI, H., SHIOHARA, M., MATSUMURA, T., MIYAGAWA, N., TANAKA, M., KOMIYAMA, A., & KURATA, S. (2003) · Pediatrics International · doi:10.1046/j.1442-200x.2003.01671.x · Cited by 253
Safety of probiotics used to reduce risk and prevent or treat disease.
(2011) · PubMed Central · Cited by 242
A review of dose-responses of probiotics in human studies
Ouwehand, A. C. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0140 · Cited by 233
Szajewska, H., & Kołodziej, M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13404 · Cited by 223
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Johnston, B. C., Goldenberg, J. Z., Vandvik, P. O., Sun, X., & Guyatt, G. H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub3 · Cited by 222
Self-citationDavis, L. M. G., Martínez, I., Walter, J., & Hutkins, R. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.10.007 · Cited by 219
Lactobacillus GG in the Prevention of Nosocomial Gastrointestinal and Respiratory Tract Infections
Hojsak, I., Abdović, S., Szajewska, H., Milošević, M., Krznarić, Ž., & Kolaček, S. (2010) · Pediatrics · doi:10.1542/peds.2009-2568 · Cited by 213
Nista, E. C., Candelli, M., Cremonini, F., Cazzato, I. A., Zocco, M. A., Franceschi, F., Cammarota, G., Gasbarrini, G., & Gasbarrini, A. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02274.x · Cited by 212
Corrêa, N. B. O., Péret Filho, L. A., Penna, F. J., Lima, F. M. L. S., & Nicoli, J. R. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000159217.47419.5b · Cited by 208
Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan
RAZA, S., GRAHAM, S. M., ALLEN, S. J., SULTANA, S., TROP, L. C. M., & HART, C. A. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199502000-00005 · Cited by 195
S??kora, J., Vale??kov??, K., Amlerov??, J., Siala, K., D??dek, P., Watkins, S., Varva??ovsk??, J., Sto??ick??, F., Pazdiora, P., & Schwarz, J. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000173855.77191.44 · Cited by 192
Johnston, B. C. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051603 · Cited by 192
Self-citationLactobacilli and Bacteremia in Southern Finland, 1989-1992
Saxelin, M., Chuang, N.-H., Chassy, B., Rautelin, H., Makela, P. H., Salminen, S., & Gorbach, S. L. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.3.564 · Cited by 186
THOMAS, M. R., LITIN, S. C., OSMON, D. R., CORR, A. P., WEAVER, A. L., & LOHSE, C. M. (2001) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)62106-x · Cited by 185
Probiotics and immune response
CUNNINGHAMRUNDLES, S. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00813-8 · Cited by 179
Szajewska, H., & Mrukowicz, J. Z. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02624.x · Cited by 175
Turck, D., Bernet, J., Marx, J., Kempf, H., Giard, P., Walbaum, O., Lacombe, A., Rembert, F., Toursel, F., Bernasconi, P., et al. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2003.tb08099.x · Cited by 174
LIONETTI, E., MINIELLO, V. L., CASTELLANETA, S. P., MAGISTÁ, A. M., DE CANIO, A., MAUROGIOVANNI, G., IERARDI, E., CAVALLO, L., & FRANCAVILLA, R. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03145.x · Cited by 169
Beausoleil, M., Fortier, N., Guénette, S., L’Ecuyer, A., Savoie, M., Franco, M., Lachaîne, J., & Weiss, K. (2007) · Canadian Journal of Gastroenterology · doi:10.1155/2007/720205 · Cited by 162
Whelan, K., & Myers, C. E. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28759 · Cited by 161
The Use of Probiotics in Gastrointestinal Disease
Madsen, K. L. (2001) · Canadian Journal of Gastroenterology · doi:10.1155/2001/690741 · Cited by 149
Ruszczyński, M., Radzikowski, A., & Szajewska, H. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03714.x · Cited by 147
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Johnston, B. C., Supina, A. L., Ospina, M. B., & Vohra, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub2 · Cited by 147
Self-citationTankanow, R. M., Ross, M. B., Ertel, I. J., Dickinson, D. G., McCormick, L. S., & GARFINKEL, J. (1990) · DICP · doi:10.1177/106002809002400408 · Cited by 140
Sussman, J. I., Baron, E. J., Goldberg, S. M., Kaplan, M. H., & Pizzarello, R. A. (1986) · Clinical Infectious Diseases · doi:10.1093/clinids/8.5.771 · Cited by 139
Honeycutt, T., Khashab, M. E., Wardrop, R. M., McNeal-Trice, K. A., Honeycutt, A. L. B., Christy, C. G., Mistry, K. P., Harris, B. D., Meliones, J. N., & Kocis, K. C. (2007) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000282176.41134.e6 · Cited by 138
Fox, M. J., Ahuja, K., Robertson, I. K., Ball, M., & Eri, R. D. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006474 · Cited by 135
The Effects of Probiotics on PPI‐Triple Therapy for Helicobacter pylori Eradication
Kim, M., Kim, N., Lee, S. H., Park, Y. S., Hwang, J., Kim, J., Jeong, S., Lee, D. H., Kim, J. S., Jung, H. C., et al. (2008) · Helicobacter · doi:10.1111/j.1523-5378.2008.00601.x · Cited by 129
Brunser, O., Gotteland, M., Cruchet, S., Figueroa, G., Garrido, D. A., & Steenhout, P. G. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000198773.40937.61 · Cited by 127
Khodadad, A., Farahmand, F., Mehri, N., & Shoaran, M. (2013) · Europe PMC (PubMed Central) · Cited by 122
Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink
Wenus, C., Goll, R., Loken, E. B., Biong, A. S., Halvorsen, D. S., & Florholmen, J. R. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602718 · Cited by 121
Role of Lactobacillus in the Prevention of Antibiotic‐Associated Diarrhea: A Meta‐analysis
Kale-Pradhan, P. B., Jassaly, H. K., & Wilhelm, S. M. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.2.119 · Cited by 113
Koning, C. J., Jonkers, D. M. A. E., Stobberingh, E. E., Mulder, L. H. C., Rombouts, F. M., & Stockbrügger, R. W. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01547.x · Cited by 111
Szajewska, H., Albrecht, P., & Topczewska-Cabanek, A. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318182e716 · Cited by 109
Duman, D., Bor, S., ??z??temiz, ?., ahin, T. L., uz, D. O., tan, F. I., Vural, T., Sandkci, M., ksal, F. I., ek, L. I., et al. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200512000-00015 · Cited by 104
Measurement Issues in Trials of Pediatric Acute Diarrheal Diseases: A Systematic Review
Johnston, B. C., Shamseer, L., da Costa, B. R., Tsuyuki, R. T., & Vohra, S. (2010) · PEDIATRICS · doi:10.1542/peds.2009-3667 · Cited by 102
Self-citationCan, M., Beşirbellioglu, B. A., Avcı, İ. Y., Beker, C. M., & Pahsa, A. (2006) · PubMed · Cited by 101
Safety of probiotics: comparison of two popular strains
Hammerman, C., Bin‐Nun, A., & Kaplan, M. (2006) · BMJ · doi:10.1136/bmj.39010.630799.be · Cited by 100
LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact
Akl, E. A., Briel, M., You, J. J., Lamontagne, F., Gangji, A. S., Cukierman‐Yaffe, T., Alshurafa, M., Sun, X., Nerenberg, K. A., Johnston, B. C., et al. (2009) · Trials · doi:10.1186/1745-6215-10-40 · Cited by 99
Self-citationLei, V., Friis, H., & Michaelsen, K. F. (2006) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2006.04.022 · Cited by 97
Hurduc, V., Pleşca, D. A., Dragomir, D., Sajin, M., & Vandenplas, Y. (2008) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.00977.x · Cited by 95
Lin, J.-S., Chiu, Y., Lin, N.-T., Chu, C.-H., Huang, K., Liao, K., & Peng, K. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.114 · Cited by 92
Michail, S. K., & Kenche, H. (2010) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-010-9059-y · Cited by 87
Imase, K., Takahashi, M., Tanaka, A., Tokunaga, K., Sugano, H., Tanaka, M., Ishida, H., Kamiya, S., & Takahashi, S. (2008) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00026.x · Cited by 81
Are live saccharom yces yeasts harmful to patients?
Piarroux, R., Millon, L., Bardonnet, K., Vagner, O., & Koenig, H. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02001-2 · Cited by 77
The Probiotic Effect of Saccharomyces boulardii in a Pediatric Age Group
Erdeve, Ö. (2004) · Journal of Tropical Pediatrics · doi:10.1093/tropej/50.4.234 · Cited by 76
Conway, S., Hart, A. R., Clark, A., & Harvey, I. M. (2007) · British Journal of General Practice · doi:10.3399/096016407782604811 · Cited by 76
Shan, L.-S., Hou, P., Wang, Z.-J., Liu, F.-R., Chen, N., Shu, L.-H., Zhang, H., Han, X.-H., Han, X.-X., Cai, X., et al. (2013) · Beneficial Microbes · doi:10.3920/bm2013.0008 · Cited by 76
Clinical Safety of Lactobacillus casei shirota as a Probiotic in Critically Ill Children
Srinivasan, R., Meyer, R. W., Ramnarayan, P., & Britto, J. F. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000189335.62397.cf · Cited by 74
La Rosa, M., Bottaro, G., Gulino, N., Gambuzza, F., Di Forti, F., Inì, G., & Tornambè, E. (2003) · PubMed · Cited by 74
National Clostridium difficile Standards Group: Report to the Department of Health
(2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.10.016 · Cited by 74
Tolone, S., Pellino, V., Vitaliti, G., Lanzafame, A., & Tolone, C. (2012) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/1824-7288-38-63 · Cited by 65
Wanke-Rytt, M., & Szajewska, H. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.12.049 · Cited by 62
Merenstein, D. J., Foster, J., & D’Amico, F. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.119 · Cited by 61
Zoppi, G., Cinquetti, M., Benini, A., Bonamini, E., & Minelli, E. B. (2001) · Current Therapeutic Research · doi:10.1016/s0011-393x(01)89006-8 · Cited by 59
Dajani, A. I., Hammour, A. A., Yang, D., Chung, P., Nounou, M., Yuan, K., Zakaria, M. A., & Schi, H. (2013) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.111953 · Cited by 59
[Treatment of acute infantile diarrhea: controlled trial of Saccharomyces boulardii].
Chapoy, P. R. (1985) · PubMed · Cited by 58
Probiotics for the treatment ofHelicobacter pyloriinfection in children
Pacifico, L., Osborn, J. F., Bonci, E., Romaggioli, S., Baldini, R., & Chiesa, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i3.673 · Cited by 56
Simakachorn, N., Bibiloni, R., Yimyaem, P., Tongpenyai, Y., Varavithaya, W., Grathwohl, D., Reuteler, G., Maire, J.-C. E., Blum, S., Steenhout, P. G., et al. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318216f1ec · Cited by 56
Schrezenmeir, J., Heller, K. J., McCue, M. J., Llamas, C. V., Lam, W., Burow, H., Kindling-Rohracker, M., Fischer, W., Sengespeik, H. C., Comer, G. M., et al. (2004) · Clinical Pediatrics · doi:10.1177/000992280404300305 · Cited by 56
Prevention of antibiotic-associated diarrhea in infants by probiotics.
Jirapinyo, P., Densupsoontorn, N., Thamonsiri, N., & Wongarn, R. (2002) · PubMed · Cited by 56
Effect of Probiotics on Helicobacter Pylori Eradication
Park, S. K., Park, D. I., Choi, J. S., Kang, M.-S., Park, J. H., Kim, H. J., Cho, Y. K., Sohn, C. I., Jeon, W. K., & Kim, B. I. (2019) · Case Medical Research · doi:10.31525/ct1-nct04034641 · Cited by 55
Szymański, H., Armańska, M., Kowalska‐Duplaga, K., & Szajewska, H. (2008) · Digestion · doi:10.1159/000151300 · Cited by 54
Lack of relationship of Clostridium difficile to antibiotic-associated diarrhea in children
Elstner, C. L., Lindsay, A. N., Book, L. S., & Matsen, J. M. (1983) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198309000-00006 · Cited by 50
Zhang, B., Xu, Y.-Z., Zhao-hui, D., Bo, C., Li-Rong, J., & Vandenplas, Y. (2015) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2015.18.1.17 · Cited by 46
MENINGITIS CAUSED BY BIFIDOBACTERIUM IN AN INFANT
Hata, D., Yoshida, A., Ohkubo, H., Mochizuki, Y., Hosoki, Y., Tanaka, R., & Azuma, R. (1988) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198809000-00018 · Cited by 44
Gogate, A., De, A., Nanivadekar, R., Mathur, M., Saraswathi, K., Jog, A. S., & Kulkarni, M. (2005) · PubMed · Cited by 43
Witsell, D. L., Garrett, C. G., Yarbrough, W. G., Dorrestein, S. P., Drake, A. F., & Weissler, M. C. (1995) · PubMed · Cited by 39
Probiotics plus antibiotics: Regulating our bacterial environment
Saavedra, J. M. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70046-6 · Cited by 39
McFarland, L. V. (2014) · Beneficial Microbes · doi:10.3920/bm2014.0034 · Cited by 37
Georgieva, M., Pancheva, R., Rasheva, N., Usheva, N., Ivanova, L. V., & Koleva, K. (2015) · Journal of IMAB - Annual Proceeding (Scientific Papers) · doi:10.5272/jimab.2015214.895 · Cited by 34
Zhao, H., Ouyang, H., Duan, B.-P., Xu, B., Chen, Z., Tang, J., & You, J. (2014) · PubMed · Cited by 22
[Oral bacterial therapy in prevention of antibiotic-induced diarrhea in childhood].
Contardi, I. (1991) · PubMed · Cited by 21
Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children
Erdeve, Ş. S., Gökay, S., & Dallar, Y. B. (2009) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2009.2291 · Cited by 19
Conceptual Framework for Health‐related Quality of Life Assessment in Acute Gastroenteritis
Johnston, B. C., Donen, R. M., Pooni, A., Pond, J., Xie, F., Giglia, L., Kam, A. J., Bhamber, A., Bami, K., Patel, Y., et al. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3182736f49 · Cited by 18
Self-citation[Clinical assessment of a new oral bacterial treatment for children with acute diarrhea].
Michielutti, F., Bertini, M., Presciuttini, B., & Andreotti, G. (1996) · PubMed · Cited by 16
İşlek, A., Sayar, E., Yılmaz, A., & Artan, R. (2015) · PubMed · Cited by 15
酪酸梭菌二聯活菌散剤予防肺炎儿童抗生素相関性下痢研究協作組 (2012) · PubMed · Cited by 11
Can Saccharomyces boulardii prevent antibiotic-associated diarrhea in children?
McFarland, L. V. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0188 · Cited by 9
Valsecchi, C., Marseglia, A., Montagna, L., Tagliacarne, S. C., Elli, M., Licari, A., Marseglia, G. L., & Castellazzi, A. M. (2014) · PubMed · Cited by 7
Saccharomyces boulardii and antibiotic‐associated diarrhoea in children
Erdeve, Ö., Tıraş, Ü., Dallar, Y., & Savas, S. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02498.x · Cited by 7
Effectivness of Probiotic on Treatment of Helicobacter Pylori Infection in Children
Saneian, H., Layegh, S., & Rahimi, H. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 6
Парфенов, А. И., Ручкина, И. Н., Tsaregorodtsev, T. M., & Serova, T. I. (2005) · PubMed · Cited by 2
Vogel, L. C. (1995) · International Journal of Trauma Nursing · doi:10.1016/s1075-4210(05)80009-4 · Cited by 1
Research works printed but not linked: 9
- Benhamou, 1999, Antibiotic-associated diarrhoea in children: A computer monitored double-blind outpatients trial comparing a protective and a probiotic agent, Médecine & Chirurgie Digestives, 28, 163
- Adam, 1977, Gaz Med Fr, 84, 2072
- Contreras, 1983, Lactobacillus acidophilus in childhood diarrhea, Compend Invest Clin Latinoam, 3, 114
- Czerwionka-Szaflarska, 2006, Effect of probiotic bacteria supplementation on the tolerance of helicobacter pylori eradication therapy in children and youth, Pediatria Polska, 81, 334
- Daschner, 1979, A saccharomyces preparation for diarrhea?, Gynakol Prax, 3, 530
- Kleinkauf, 1959, The use of resistant acidophilus strains during antibiotic therapy, Arch Kinderheilk, 160, 51
- Pancheva, 2009, A randomized controlled trial on the effect of a combination of lactobacillus acidophilus, lactobacillus delbruecki subsp. bulgaricus and bifidobacterium bifidumin the prophylaxis of vomiting and diarrhoea of hospitalised children 1 to 7 years of age, J Pediatr Gastroenterol Nutr, 48, E111
- Penna, 2009, Lack of effect of Lactobacillus delbrueckii H2B20 in the prevention of diarrhea in children hospitalized for short period, Pediatria (São Paulo), 31, 76
- Plewińska, 2006, Probiotics in the treatment of Helicobacter pylori infection in children, Gastroenterologia Polska, 13, 315
Cited by
Role of the gut microbiota in nutrition and health
Valdes, A. M., Walter, J., Segal, E., & Spector, T. D. (2018) · BMJ · doi:10.1136/bmj.k2179 · Cited by 2,375
Probiotics and prebiotics in intestinal health and disease: from biology to the clinic
Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R., & Rastall, R. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0173-3 · Cited by 2,059
The pros, cons, and many unknowns of probiotics
Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019) · Nature Medicine · doi:10.1038/s41591-019-0439-x · Cited by 1,398
Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature
Fijan, S. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110504745 · Cited by 1,059
Langdon, A., Crook, N., & Dantas, G. (2016) · Genome Medicine · doi:10.1186/s13073-016-0294-z · Cited by 912
Metadata
- Authors
- Goldenberg, J. Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., & Johnston, B. C.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2015-12-22
- Volume
- 4
- Issue
- 12
- Pages
- CD004827-CD004827
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2152382096
- Cited by
- 607
- References
- 135
- FWCI
- 60.63
- Type
- journal article
- Language
- en
- Update notices
- new_version (2019-04-30)
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.